Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00209131 · ClinicalTrials.gov registry record · NA
Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00209131 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 24 participants.
The verdict
NCT00209131, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.
Interventions
- DRUG Sugar pill
- DRUG Flomax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00209131
The ClinicalTrials.gov registry entry for NCT00209131 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugar pill is the first listed.
NCT00209131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00209131 about?
NCT00209131 is a clinical study titled "Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy". The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.
What is the current status of trial NCT00209131?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2005-04. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00209131?
The interventions under investigation include: Sugar pill (DRUG), Flomax (DRUG).
Who is sponsoring clinical trial NCT00209131?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.